“What’s New in ME/CFS?” Why Heterogeneity is the Key to Breakthroughs
In our “What’s New in ME/CFS?” series, we spotlight researchers transforming what we know about
May 4, 2026
In our “What’s New in ME/CFS?” series, we spotlight researchers transforming what we know about
When an organization, like a government agency, company, or nonprofit, considers a big change or
Glucagon-Like Peptide-1 (GLP-1) agonist medications, like semaglutide, are injectable or oral drugs that mimic the
Dr. Karen Bonuck is professor of family and social medicine at Albert Einstein College of
A quick note to loop you in on another appropriations effort we’re in support of
We’re proud to announce that Solve CEO Emily Taylor has been selected for the 2026–2027
In our “What’s New in ME/CFS?” series, we spotlight researchers transforming what we can do
Advocacy Week 2026 starts this Monday, March 23rd, and this year we’re doing something different.
Solve M.E. and #MEAction are joining forces for a week of coordinated action designed to
Every year on March 15, our community pauses to recognize Long Covid Awareness Day—a day
Appropriations season is moving fast this year, and we are proud to share that Solve
Dear friends, This year, Solve M.E. & #MEAction are partnering on a medical education initiative.